1
|
Pudsey L, Haworth A, White P, Moutrie Z, Jonker B, Foote M, Poder J. Current status of intra-cranial stereotactic radiotherapy and stereotactic radiosurgery in Australia and New Zealand: key considerations from a workshop and surveys. Phys Eng Sci Med 2022; 45:251-259. [PMID: 35113342 PMCID: PMC8901507 DOI: 10.1007/s13246-022-01108-4] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2021] [Accepted: 01/20/2022] [Indexed: 12/22/2022]
Abstract
Recently, there has been increased interest worldwide in the use of conventional linear accelerator (linac)-based systems for delivery of stereotactic radiosurgery/radiotherapy (SRS/SRT) contrasting with historical delivery in specialised clinics with dedicated equipment. In order to gain an understanding and define the current status of SRS/SRT delivery in Australia and New Zealand (ANZ) we conducted surveys and provided a single-day workshop. Prior to the workshop ANZ medical physicists were invited to complete two surveys: a departmental survey regarding SRS/SRT practises and equipment; and an individual survey regarding opinions on current and future SRS/SRT practices. At the workshop conclusion, attendees completed a second opinion-based survey. Workshop discussion and survey data were utilised to identify areas of consensus, and areas where a community consensus was unclear. The workshop was held on the 8th Sept 2020 virtually due to pandemic-related travel restrictions and was attended by 238 radiation oncology medical physicists from 39 departments. The departmental survey received 32 responses; a further 89 and 142 responses were received to the pre-workshop and post-workshop surveys respectively. Workshop discussion indicated a consensus that for a department to offer an SRS/SRT service, a minimum case load should be considered depending on availability of training, peer-review, resources and equipment. It was suggested this service may be limited to brain metastases only, with less common indications reserved for departments with comprehensive SRS/SRT programs. Whilst most centres showed consensus with treatment delivery techniques and image guidance, opinions varied on the minimum target diameter and treatment margin that should be applied.
Collapse
Affiliation(s)
- Lauren Pudsey
- Centre for Medical Radiation Physics, University of Wollongong, Wollongong, NSW, Australia
| | - Annette Haworth
- Institute of Medical Physics, School of Physics, University of Sydney, Sydney, Australia
| | - Paul White
- Nelune Comprehensive Cancer Centre, Prince of Wales Hospital, Sydney, NSW, Australia
| | - Zoe Moutrie
- Department of Radiation Oncology, Mater Hospital, GenesisCare, Crows Nest, Sydney, NSW, Australia
| | - Benjamin Jonker
- RPA Institute of Academic Surgery, University of Sydney, Sydney, Australia
| | - Matthew Foote
- University of Queensland, Princess Alexandra Hospital, ICON Cancer Care Queensland, Southport, Australia
| | - Joel Poder
- Centre for Medical Radiation Physics, University of Wollongong, Wollongong, NSW, Australia.
- St George Hospital Cancer Care Centre, Kogarah, NSW, Australia.
| |
Collapse
|
2
|
Charles PH, Crowe SB, Kairn T. Technical Note: Small field dose correction factors for radiochromic film in lung phantoms. Med Phys 2021; 48:2667-2672. [PMID: 33619729 DOI: 10.1002/mp.14799] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2020] [Revised: 02/02/2021] [Accepted: 02/16/2021] [Indexed: 12/20/2022] Open
Abstract
PURPOSE Radiochromic film has been established as a detector that can be used without the need for perturbation correction factors for small field dosimetry in water. However, perturbation factors in low density media such as lung have yet to be published. This study calculated the factors required to account for the perturbation of radiochromic film when used for small field dosimetry in lung equivalent material. METHOD Monte Carlo simulations were used to calculate dose to Gafchromic EBT3 film when placed inside a lung phantom. The beam simulated had a nominal energy of 6 MV and the field sizes simulated ranged from 10 × 10 mm2 to 30 × 30 mm2 . The lung density simulated was varied between 0.2 and 0.3 g/cm3 . Each simulation was repeated with the film replaced by lung material (the same as the surrounding medium), and the required correction factors for film dosimetry in lung ( D M e d , Q D D e t , Q ) were calculated by dividing the dose in lung by the dose in film. RESULTS For field sizes 30 × 30 mm2 and larger, no correction factors were required. At a 20 × 20 mm2 field size, small corrections were required, but were within the approximate accuracy of film dosimetry (~2%). For a 10 × 10 mm2 field size, significant correction factors need to be applied (0.935 for lung density of 0.20 g/cm3 to 0.963 for lung density of 0.30 g/cm3 ). The values lower than one mean that the film is over-responding. At the "upstream" lung-water interface the correction factors were close to unity; while at the downstream interface the corrections required were marginally smaller to those at the center of lung. One centimeter or more away from the interfaces, the correction factor did not vary as a function distance from the interface (in the beam direction). Away from the central axis (perpendicular to the beam direction), the correction factors increased slightly (away from unity) as a function of off-axis distance, before abruptly changing direction at the penumbra, with the film actually under-responding by ~10% outside the field edges. CONCLUSION Accurate dosimetry of very small fields (15 × 15 mm2 or smaller) using radiochromic film requires correction factors for the perturbation of the film on the surrounding lung material. This correction factor was as high as 6.5% for a 10 × 10 mm2 field size and a density of 0.2 g/cm3 . This will increase if either the density or the field size decrease further. This correction factor does not vary as a function of depth in lung once charged particle equilibrium is established.
Collapse
Affiliation(s)
- Paul H Charles
- Herston Biofabrication Institute, Metro North Hospital and Health Service, Herston, Queensland, 4029, Australia.,School of Information Technology and Electrical Engineering, University of Queensland, St Lucia, Queensland, 4072, Australia.,School of Chemistry and Physics, Queensland University of Technology, Brisbane, Queensland, 4000, Australia
| | - Scott B Crowe
- Herston Biofabrication Institute, Metro North Hospital and Health Service, Herston, Queensland, 4029, Australia.,School of Information Technology and Electrical Engineering, University of Queensland, St Lucia, Queensland, 4072, Australia.,School of Chemistry and Physics, Queensland University of Technology, Brisbane, Queensland, 4000, Australia.,Cancer Care Services, Royal Brisbane & Women's Hospital, Herston, Queensland, 4029, Australia
| | - Tanya Kairn
- Herston Biofabrication Institute, Metro North Hospital and Health Service, Herston, Queensland, 4029, Australia.,School of Information Technology and Electrical Engineering, University of Queensland, St Lucia, Queensland, 4072, Australia.,School of Chemistry and Physics, Queensland University of Technology, Brisbane, Queensland, 4000, Australia.,Cancer Care Services, Royal Brisbane & Women's Hospital, Herston, Queensland, 4029, Australia
| |
Collapse
|